Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
MYPI2025005794A0Undetermined Publication Date: 2021-07-15PROTAGONIST THERAPEUTICS INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025005794
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-01-15
- Filing Date
- 2021-01-14
- Publication Date
- 2021-07-15
Abstract
The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.
Need to check novelty before this filing date? Find Prior Art
